Gene Symbol | SLC22A2 |
---|---|
Entrez Gene | 6582 |
Alt Symbol | OCT2 |
Species | Human |
Gene Type | protein-coding |
Description | solute carrier family 22 (organic cation transporter), member 2 |
Other Description | organic cation transporter 2|solute carrier family 22 member 2 |
Swissprots | Q6PIQ8 Q9NQB9 Q5T7Q6 O15244 Q8NG62 |
Accessions | CAB96133 EAW47601 EAW47602 O15244 AB075951 BAC02720 AK290787 BAF83476 BC030978 AAH30978 BC039899 AAH39899 X98333 CAA66978 NM_003058 NP_003049 NM_153191 |
Function | Mediates tubular uptake of organic compounds from circulation. Mediates the influx of agmatine, dopamine, noradrenaline (norepinephrine), serotonin, choline, famotidine, ranitidine, histamin, creatinine, amantadine, memantine, acriflavine, 4-[4-(dimethylamino)-styryl]-N-methylpyridinium ASP, amiloride, metformin, N-1-methylnicotinamide (NMN), tetraethylammonium (TEA), 1-methyl-4-phenylpyridinium (MPP), cimetidine, cisplatin and oxaliplatin. Cisplatin may develop a nephrotoxic action. Transport of creatinine is inhibited by fluoroquinolones such as DX-619 and LVFX. This transporter is a major determinant of the anticancer activity of oxaliplatin and may contribute to antitumor specificity. {ECO:0000269|PubMed:12089365, ECO:0000269|PubMed:12538837, ECO:0000269|PubMed:15496291, ECO:0000269|PubMed:15783073, ECO:0000269|PubMed:16006492, ECO:0000269|PubMed:16272756, ECO:0000269|PubMed:16314463, ECO:0000269|PubMed:16394027, ECO:0000269|PubMed:16914559, ECO:0000269|PubMed:16951202, ECO:0000269 |
Subcellular Location | Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}. |
Tissue Specificity | Mainly expressed in kidney. Localized at the luminal membrane and basolateral membrane of kidney distal tubule and proximal tubules. To a lower extent, expressed in neurons of the cerebral cortex and in various subcortical nuclei (at protein levels). Also detected in secretory phase endometrium; in scattered cells in the stroma. {ECO:0000269|PubMed:11912245, ECO:0000269|PubMed:17393420, ECO:0000269|PubMed:9260930, ECO:0000269|PubMed:9687576}. |
Top Pathways | Choline metabolism in cancer |
Human SLC22A2 full length protein - ab159537 from Abcam
|
||||||||||
Human SLC22A2 protein fragment - ab159538 from Abcam
|
||||||||||
SLC22A2 Antibody Blocking Peptide - LS-E6189 from LifeSpan Bioscience
|
||||||||||
Recombinant Human SLC22A2/OCT2 Protein - H00006582-Q01 from Novus Biologicals
|
||||||||||
Recombinant Human SLC22A2/OCT2 Protein - H00006582-P01 from Novus Biologicals
|
||||||||||
SLC22A2-Antibody-C-term-Blocking-Peptide - BP18829b from Abgent, a WuXi AppTec company
|
||||||||||
OCT2 peptide - orb72254 from Biorbyt
|
||||||||||
SLC22A2 peptide - orb217945 from Biorbyt
|
||||||||||
SLC22A2 Blocking Peptide - 33R-6311 from Fitzgerald
|
||||||||||
OCT2 Blocking Peptide - abx063276 from Abbexa
|
||||||||||
OCT2 Blocking Peptide - abx063107 from Abbexa
|
||||||||||
SLC22A2 / OCT2 - H00006582-P01 from Acris Antibodies
|
||||||||||
SLC22A2 fusion protein - ag4968 from Proteintech Group
|
||||||||||
SLC22A2 fusion protein - ag4500 from Proteintech Group
|
||||||||||
OCT2 Blocking Peptide - CBP2082 from Cohesion Biosciences
|
||||||||||
SLC22A2 Peptide - BS60420P from Bioworld Technology
|
||||||||||
SLC22A2 Protein - abx163589 from Abbexa
|
||||||||||
SLC22A2/OCT2 Protein - NBP1-89417PEP from Novus Biologicals
|
||||||||||
SLC22A2-Blocking-Peptide-N-term - BP21683a from Abgent, a WuXi AppTec company
|
||||||||||
SLC22A2 Peptide, Human - M34GP14384H from Creative Peptides
|
||||||||||
SLC22A2/OCT2 Recombinant Protein Antigen - NBP2-52942PEP from Novus Biologicals
|
||||||||||
Solute carrier family 22 member 2 (SLC22A2), Recombinant Protein - MBS1165458 from MyBioSource
|
||||||||||
Solute carrier family 22 member 2 (SLC22A2), Recombinant Protein - MBS7085567 from MyBioSource
|
||||||||||
SLC22A2/OCT2 Recombinant Protein Antigen - NBP2-52941PEP from Novus Biologicals
|
||||||||||
Recombinant Human SLC22A2 Protein, GST-tagged - SLC22A2-670H from Creative Biomart
|